Medipharm Labs Corp T.LABS

I believe LABS provided 'input' & 'guidance' to the DEA on

[subaru1i]

rescheduling from 1 to 3 because Keith Strachan in the CC, a Canadian living in Canada said something very intersting and to me extremely forward looking, and NOT by chance or off the cuff comments, especially holding a position in senior management of the company and making those statements publicly to all shareholders.    

Keith said, summarizing...

1) New strict rules
2) FDA oversight

So....you should be asking yourself now....how does Keith know to make those comments during the CC.  

Thank you Athea for your 'thought starter'.